Multiple Sclerosis: Symptom Onset, Variability, and Disease Courses

Multiple sclerosis (MS) is a chronic immune-mediated demyelinating disease of the CNS. Onset typically 20–50 years (peak 30s); women 3:1.

Common Initial Presentations

  • Optic neuritis (unilateral vision loss, pain with eye movement)
  • Sensory: Numbness, tingling, band-like sensation (partial transverse myelitis)
  • Motor: Weakness, spasticity, gait disturbance
  • Brainstem: Diplopia (INO), vertigo, dysarthria, dysphagia
  • Cerebellar: Ataxia, tremor, dysmetria
  • Autonomic: Neurogenic bladder/bowel, sexual dysfunction
  • Cognitive: Processing speed, memory, executive function
  • Fatigue (80%), Uhthoff’s phenomenon (heat-worsening)

Disease Courses (2013 Phenotype)

  • CIS: First demyelinating event; may or may not progress to MS.
  • RRMS (85%): Relapses with full/partial remission; no progression between.
  • SPMS: Initial RRMS then gradual progression ± relapses.
  • PPMS (15%): Progression from onset; no distinct relapses.

Diagnosis

McDonald criteria: Dissemination in space (MRI lesions in ≥2 of 4 CNS regions) + dissemination in time (new lesion/enhancing lesion) + CSF oligoclonal bands.

Treatment

DMTs (disease-modifying therapies) reduce relapse rate, slow progression: interferons, glatiramer, S1P modulators, anti-CD20, natalizumab, cladribine, BTK inhibitors (emerging). Symptomatic management, rehab, wellness.

Multiple Sclerosis - Related Articles